Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use
Clinical trial NCT04112095 · COMPLETED
Trial details
- NCT number
- NCT04112095
- Sponsor
- HRA Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-06
- Primary completion
- 2021-08-05
- Enrollment
- 962
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.